HRTS vs. FMED ETF Comparison
Comparison of Tema Cardiovascular and Metabolic ETF (HRTS) to Fidelity Disruptive Medicine ETF (FMED)
HRTS
Tema Cardiovascular and Metabolic ETF
HRTS Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$33.47
Average Daily Volume
23,011
8
FMED
Fidelity Disruptive Medicine ETF
FMED Description
The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.Grade (RS Rating)
Last Trade
$26.15
Average Daily Volume
5,062
10
Performance
| Period | HRTS | FMED |
|---|---|---|
| 30 Days | -5.29% | 0.50% |
| 60 Days | -0.95% | 5.33% |
| 90 Days | 1.42% | 10.05% |
| 12 Months | 19.47% |
1 Overlapping Holdings
| Symbol | Grade | Weight in HRTS | Weight in FMED | Overlap | |
|---|---|---|---|---|---|
| ALNY | B | 5.3% | 4.64% | 4.64% |
HRTS: Top Represented Industries & Keywords
FMED: Top Represented Industries & Keywords
Compare ETFs
